U.S., Jan. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07316088) titled 'Determining the Potential for Efficacy of OTX-601 in Reducing PTSD Symptoms' on Dec. 30, 2025.
Brief Summary: This study is exploring the efficacy of a digital therapeutic app in reducing symptoms of posttraumatic stress disorder (PTSD) in adults.
Study Start Date: Dec. 09, 2025
Study Type: INTERVENTIONAL
Condition:
PTSD
Post Traumatic Stress Disorder
Intervention:
DEVICE: OTX-601 Digital Therapeutic
Prescription digital therapeutic designed to overcome existing barriers and deliver evidence-based treatment for PTSD
DEVICE: OTX-003 Comparator app
Comparator designed to match interface of intervention while providing no activ...